Tag: GLP-1
-
GLP-1 Medications and Pregnancy: Interpreting Early Signals and Risks
Understanding GLP-1 Medications and Pregnancy GLP-1 receptor agonists, such as Ozempic (semaglutide), are widely prescribed for type 2 diabetes and some cases of obesity treatment. They work by mimicking an incretin hormone that helps regulate blood sugar and appetite. When considering pregnancy, however, medical guidance has historically recommended avoiding GLP-1 medications because of potential risks…
-
GLP-1 Drugs and Pregnancy: Early Signals of Risk But With Caveats
Overview: GLP-1 medications and pregnancy Glucagon-like peptide-1 (GLP-1) receptor agonists, including Ozempic (semaglutide) and similar drugs, are widely used for type 2 diabetes and obesity treatment. Recent studies have explored potential links between GLP-1 use and pregnancy outcomes. The emerging signals are not definitive, and experts emphasize cautious interpretation. The key takeaway is that these…
-
GLP-1 Medications and Pregnancy: Early Signals, Important Caveats
Overview: GLP-1 Drugs and Pregnancy Concerns Glucagon-like peptide-1 (GLP-1) receptor agonists, including popular medications like Ozempic, are widely used to manage type 2 diabetes and support weight loss. Recent studies have raised questions about potential pregnancy-related risks for people taking these drugs. However, researchers stress that the data are preliminary, come with important caveats, and…
-
Drugs Without Nausea: Scientists Target Brain Circuits to Separate Side Effects from Weight-Loss Benefits
Overview: Aiming for Nausea-Free Weight-Loss Drugs Nausea has long been a common hurdle for people using weight-loss medications such as Ozempic and other GLP-1 receptor agonists. While these drugs can help curb appetite and promote weight loss, the unpleasant side effect of nausea can limit adherence and diminish quality of life. In response, scientists are…
-
Can Weight-Loss Drugs Be Nausea-Free? Scientists Target Brain Pathways
Can weight-loss drugs be nausea-free? For millions of people seeking safer and more tolerable weight-loss options, the promise of nausea-free medications is steadily moving from rumor to research reality. Drugs like Ozempic (semaglutide) and other GLP-1 receptor agonists have helped many shed pounds by suppressing appetite and improving metabolic health. But side effects—especially nausea, vomiting,…
-
Overcoming Nausea: The Next Wave of Weight-Loss Drugs and Safer Experiences
Search for a ‘painless’ path to weight loss Millions of Americans have found success with prescription medications like Wegovy and Zepbound, which help reduce appetite and boost weight loss. Yet the journey isn’t the same for everyone. A common obstacle is nausea, a side effect that can range from mild discomfort to significant disruption in…
-
Brain scientists pursue nausea-free weight-loss drugs amid GLP-1 breakthroughs
Overview: The quest for nausea-free weight-loss medications Millions of Americans have achieved impressive weight loss with medications such as Wegovy and Zepbound, which target the body’s GLP-1 pathways to curb appetite and boost metabolic effects. Yet the journey with these drugs isn’t without rough edges. Nausea, vomiting, and other gastrointestinal side effects remain common early…
-
Brain scientists pursue nausea-free weight-loss drugs to improve outcomes
Overview: The quest for nausea-free weight-loss drugs Across the United States and beyond, millions have found success shedding pounds with medications such as Wegovy and Zepbound. These GLP-1 receptor agonists help reduce appetite and slow digestion, leading to meaningful weight loss for many individuals. Yet the journey isn’t without its rough edges. A sizable share…
-
Brain Recordings Show Short-Lived Impact of Tirzepatide on Food Cravings
New insights into tirzepatide’s neural effects In a rare peek inside the brains of people with obesity and loss of control eating, researchers used brain recordings to study how tirzepatide—a drug sold as Mounjaro and Zepbound—affects cravings. The findings, though preliminary, suggest that the medication can acutely suppress activity in brain regions tied to reward…
-
Could Ozempic and Wegovy Cut Colon Cancer Mortality? New Study Sparks Hope
Surprising findings from a new study In recent months, researchers have turned their attention to whether GLP-1 receptor agonists—drugs best known for aiding weight loss—might also influence cancer outcomes. Ozempic (semaglutide) and Wegovy (semaglutide for chronic weight management) belong to this class. A fresh analysis indicates that users of these medications could experience a meaningful…